» Articles » PMID: 23349738

A Systematic Review of Recent Clinical Practice Guidelines on the Diagnosis, Assessment and Management of Hypertension

Overview
Journal PLoS One
Date 2013 Jan 26
PMID 23349738
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the availability of clinical practice guidelines (CPGs), optimal hypertension control is not achieved in many parts of the world; one of the challenges is the volume of guidelines on this topic and their variable quality. To systematically review the quality, methodology, and consistency of recommendations of recently-developed national CPGs on the diagnosis, assessment and the management of hypertension.

Methodology/principal Findings: MEDLINE, EMBASE, guidelines' websites and Google were searched for CPGs written in English on the general management of hypertension in any clinical setting published between January 2006 and September 2011. Four raters independently appraised each CPG using the AGREE-II instrument and 2 reviewers independently extracted the data. Conflicts were resolved by discussion or the involvement of an additional reviewer. Eleven CPGs were identified. The overall quality ranged from 2.5 to 6 out of 7 on the AGREE-II tool. The highest scores were for "clarity of presentation" (44.4%-88.9%) and the lowest were for "rigour of development" (8.3%-30% for 9 CGPs). None of them clearly reported being newly developed or adapted. Only one reported having a patient representative in its development team. Systematic reviews were not consistently used and only 2 up-to-date Cochrane reviews were cited. Two CPGs graded some recommendations and related that to levels (but not quality) of evidence. The CPGs' recommendations on assessment and non-pharmacological management were fairly consistent. Guidelines varied in the selection of first-line treatment, adjustment of therapy and drug combinations. Important specific aspects of care (e.g. resistant hypertension) were ignored by 6/11 CPGs. The CPGs varied in methodological quality, suggesting that their implementation might not result in less variation of care or in better health-related outcomes.

Conclusions/significance: More efforts are needed to promote the realistic approach of localization or local adaptation of existing high-quality CPGs to the national context.

Citing Articles

An assessment of variation in quality of hypertension guidelines across income settings using the AGREE II tool.

Philip R, Janssen C, Jose A, Beaney T, Clarke J Wellcome Open Res. 2024; 9:526.

PMID: 39606620 PMC: 11599801. DOI: 10.12688/wellcomeopenres.22699.1.


The quality of guidelines for treatment of carotid artery disease: a critical appraisal using the AGREE II instrument.

Coutinho S, Ricardo J, Coutinho A, Cavalcante L J Vasc Bras. 2022; 21:e20220032.

PMID: 36505346 PMC: 9716357. DOI: 10.1590/1677-5449.202200321.


Concordance of recommendations across clinical practice guidelines for the management of hypertension in Southeast Asia with internationally reputable sources.

Kow C, Hasan S, Wong P, Verma R BMC Cardiovasc Disord. 2021; 21(1):354.

PMID: 34320925 PMC: 8317337. DOI: 10.1186/s12872-021-02054-x.


Guidelines for the management of pregnant women with obesity: A systematic review.

Simon A, Pratt M, Hutton B, Skidmore B, Fakhraei R, Rybak N Obes Rev. 2020; 21(3):e12972.

PMID: 31943650 PMC: 7064940. DOI: 10.1111/obr.12972.


Family physicians' experience and understanding of evidence-based practice and guideline implementation in primary care practice, Cape Town, South Africa.

Pather M, Mash R Afr J Prim Health Care Fam Med. 2019; 11(1):e1-e10.

PMID: 31170792 PMC: 6556914. DOI: 10.4102/phcfm.v11i1.1592.


References
1.
Hodgkinson J, Mant J, Martin U, Guo B, Hobbs F, Deeks J . Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011; 342:d3621. PMC: 3122300. DOI: 10.1136/bmj.d3621. View

2.
Whitworth J . 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21(11):1983-92. DOI: 10.1097/00004872-200311000-00002. View

3.
Law M, Morris J, Wald N . Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338:b1665. PMC: 2684577. DOI: 10.1136/bmj.b1665. View

4.
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield M . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009; 27(11):2121-58. DOI: 10.1097/HJH.0b013e328333146d. View

5.
Lloyd-Jones D, Adams R, Carnethon M, de Simone G, Ferguson T, Flegal K . Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119(3):480-6. DOI: 10.1161/CIRCULATIONAHA.108.191259. View